- Home
- AU vs BNTX Comparison
AU vs BNTX Comparison
Compare AU & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AU
- BNTX
- Stock Information
- Founded
- AU 1944
- BNTX 2008
- Country
- AU United States
- BNTX Germany
- Employees
- AU N/A
- BNTX N/A
- Industry
- AU Precious Metals
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AU Basic Materials
- BNTX Health Care
- Exchange
- AU Nasdaq
- BNTX Nasdaq
- Market Cap
- AU 30.2B
- BNTX 26.4B
- IPO Year
- AU 1972
- BNTX 2019
- Fundamental
- Price
- AU $66.33
- BNTX $96.74
- Analyst Decision
- AU Buy
- BNTX Strong Buy
- Analyst Count
- AU 5
- BNTX 18
- Target Price
- AU $47.30
- BNTX $139.49
- AVG Volume (30 Days)
- AU 3.1M
- BNTX 1.1M
- Earning Date
- AU 11-06-2025
- BNTX 11-03-2025
- Dividend Yield
- AU 1.39%
- BNTX N/A
- EPS Growth
- AU 1303.37
- BNTX N/A
- EPS
- AU 3.81
- BNTX N/A
- Revenue
- AU $7,649,000,000.00
- BNTX $3,380,387,551.00
- Revenue This Year
- AU $62.30
- BNTX N/A
- Revenue Next Year
- AU N/A
- BNTX $15.19
- P/E Ratio
- AU $17.42
- BNTX N/A
- Revenue Growth
- AU 54.59
- BNTX 6.98
- 52 Week Low
- AU $22.45
- BNTX $81.20
- 52 Week High
- AU $66.45
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- AU 77.60
- BNTX 37.48
- Support Level
- AU $56.68
- BNTX $99.90
- Resistance Level
- AU $60.36
- BNTX $104.48
- Average True Range (ATR)
- AU 1.70
- BNTX 4.24
- MACD
- AU 0.83
- BNTX -0.47
- Stochastic Oscillator
- AU 99.02
- BNTX 26.73
About AU AngloGold Ashanti PLC
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.